Your browser doesn't support javascript.
loading
Enhancing capsule in hepatocellular carcinoma: intra-individual comparison between CT and MRI with extracellular contrast agent.
Cannella, Roberto; Ronot, Maxime; Sartoris, Riccardo; Cauchy, Francois; Hobeika, Christian; Beaufrere, Aurélie; Trapani, Loïc; Paradis, Valérie; Bouattour, Mohamed; Bonvalet, Fanny; Vilgrain, Valérie; Dioguardi Burgio, Marco.
Afiliación
  • Cannella R; Department of Radiology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France; Section of Radiology - BiND, University Hospital "Paolo Giaccone", 90127 Palermo, Italy; Department of Health Promotion Sciences Maternal and Infant Care, Internal Medicine and Medical Specialties, PROMISE, University of Pal
  • Ronot M; Department of Radiology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France; Université de Paris, Faculté de Médecine & INSERM U1149 "centre de recherche sur l'inflammation", CRI, F-75018 Paris, France.
  • Sartoris R; Department of Radiology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France; Université de Paris, Faculté de Médecine & INSERM U1149 "centre de recherche sur l'inflammation", CRI, F-75018 Paris, France.
  • Cauchy F; Department of HPB Surgery and Liver Transplantation, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France.
  • Hobeika C; Department of HPB Surgery and Liver Transplantation, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France.
  • Beaufrere A; Department of Pathology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France.
  • Trapani L; Department of Pathology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France.
  • Paradis V; Department of Pathology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France.
  • Bouattour M; Department of Digestive Oncology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France.
  • Bonvalet F; Department of Radiology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France.
  • Vilgrain V; Department of Radiology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France; Université de Paris, Faculté de Médecine & INSERM U1149 "centre de recherche sur l'inflammation", CRI, F-75018 Paris, France.
  • Dioguardi Burgio M; Department of Radiology, AP-HP.Nord, Hôpital Beaujon, 92110 Clichy, France; Université de Paris, Faculté de Médecine & INSERM U1149 "centre de recherche sur l'inflammation", CRI, F-75018 Paris, France. Electronic address: marco.dioguardiburgio@aphp.fr.
Diagn Interv Imaging ; 102(12): 735-742, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34284951
ABSTRACT

PURPOSE:

The purpose of this study was to compare the value of contrast-enhanced computed tomography (CT) to that of magnetic resonance imaging obtained with extracellular contrast agent (ECA-MRI) for the diagnosis of a tumor capsule in hepatocellular carcinoma (HCC) using histopathologic findings as the standard of reference. MATERIALS AND

METHODS:

This retrospective study included patients with pathologically-proven resected HCCs with available preoperative contrast-enhanced CT and ECA-MRI examinations. Two blinded radiologists independently reviewed contrast-enhanced CT and ECA-MRI examinations to assess the presence of an enhancing capsule. The histopathological analysis of resected specimens was used as reference for the diagnosis of a tumor capsule. The sensitivity and specificity of CT and ECA-MRI for the diagnosis of a tumor capsule were determined, and an intra-individual comparison of imaging modalities was performed using McNemar test. Inter-reader agreement was assessed using Kappa test.

RESULTS:

The study population included 199 patients (157 men, 42 women; mean age 61.3 ± 13.0 [SD] years) with 210 HCCs (mean size 56.7 ± 43.7 [SD] mm). A tumor capsule was present in 157/210 (74.8%) HCCs at histopathologic analysis. Capsule enhancement was more frequently visualized on ECA-MRI (R1, 68.6%; R2, 71.9%) than on CT (R1, 44.3%, P < 0.001; R2, 47.6%, P < 0.001). The sensitivity of ECA-MRI was better for the diagnosis of histopathological tumor capsule (R1, 76.4%; R2, 79.6%; P < 0.001), while CT had a greater specificity (R1, 84.9%; R2, 83.0%; P < 0.001). Inter-reader agreement was moderate both on CT (kappa = 0.55; 95% confidence interval [CI] 0.43-0.66) and ECA-MRI (kappa = 0.57; 95% CI 0.45-0.70).

CONCLUSION:

Capsule enhancement was more frequently visualized on ECA-MRI than on CT. The sensitivity of ECA-MRI was greater than that of CT, but the specificity of CT was better than that of ECA-MRI.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diagn Interv Imaging Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diagn Interv Imaging Año: 2021 Tipo del documento: Article
...